TCTCN (Formerly BMTCN) Transplantation and Cellular Therapy Certified Nurse is a trademark of its owner, which is not affiliated with and does not endorse Test Treasure Publication or TTP Prep.
Save your progress. Create a free account to keep your scores on every device.
Create free accountNot started
Answer a few practice questions to get your score.
0 days
Study today to start a streak
0 of the last 14 days
Based on your most recent practice answers in each section.
200 practice questions, 21 chapters and 180 flashcards, across 141 sections.
| Section | Questions | Chapters | Flashcards |
|---|---|---|---|
| Administration | 41 | — | — |
| Quality of Life | 16 | 2 | 25 |
| Transplant Process and Infusion | 4 | 3 | 22 |
| Conditioning | 2 | — | — |
| Professional Performance | 2 | 2 | 41 |
| Progenitor Cells | 1 | — | — |
| Match Probability | 1 | — | — |
| Lymphocyte Recovery | 1 | — | — |
| Unrelated Donor Matching Loci | 1 | — | — |
| Allogeneic Versus Autologous Choice | 1 | — | — |
| Of Autologous Rescue | 1 | — | — |
| Cells Recognize Tumor | 1 | — | — |
| Myeloma Consolidation | 1 | — | — |
| Aplastic Anemia Plan | 1 | — | — |
| Autologous Hsct For Immune Disease | 1 | — | — |
| As Donors | 1 | — | — |
| Twin Donor | 1 | — | — |
| Infusion | 1 | — | — |
| Bispecific Antibody Versus Car T | 1 | — | — |
| Therapy Product | 1 | — | — |
| Compared With Marrow | 1 | — | — |
| Blood Limitation | 1 | — | — |
| Material For Til | 1 | — | — |
| Pretransplant Organ Testing | 1 | — | — |
| Caregiver Plan | 1 | — | — |
| Pressured Sibling Donor | 1 | — | — |
| Symptom During G-Csf | 1 | — | — |
| Calcineurin Inhibitor Level | 1 | — | — |
| Prophylaxis Dose | 1 | — | — |
| Gvhd Grade | 1 | — | — |
| Before Engraftment | 1 | — | — |
| And Liver Pain | 1 | — | — |
| Rash At Count Recovery | 1 | — | — |
| Month Out | 1 | — | — |
| Second Week | 1 | — | — |
| Vision Change, Seizure | 1 | — | — |
| Neutrophil Recovery | 1 | — | — |
| Haploidentical Infusion | 1 | — | — |
| Mouth After Melphalan | 1 | — | — |
| After Antibiotics | 1 | — | — |
| Chronic Gvhd | 1 | — | — |
| Exertional Dyspnea | 1 | — | — |
| About Photopheresis | 1 | — | — |
| During Immunosuppression | 1 | — | — |
| About Fever | 1 | — | — |
| Cold Intolerance | 1 | — | — |
| With Walking | 1 | — | — |
| At Survivorship Visit | 1 | — | — |
| Donor Chimerism | 1 | — | — |
| Fever and Hypotension After Infusion | 1 | — | — |
| Oxygen Needs and Crs Grade | 1 | — | — |
| Early Fever With Neutropenia | 1 | — | — |
| Scoring A Neurologic Check | 1 | — | — |
| Confusion Without Fever | 1 | — | — |
| Sudden Neurologic Event | 1 | — | — |
| New Hypotension, No Fever | 1 | — | — |
| Laboratory Trend After Crs | 1 | — | — |
| Purpose of Small First Doses | 1 | — | — |
| Counts That Fall Again | 1 | — | — |
| Prophylaxis With Prolonged Steroids | 1 | — | — |
| Relapse After Cd19 Therapy | 1 | — | — |
| Crs Not Improving | 1 | — | — |
| Continuous Infusion Safety | 1 | — | — |
| Discharge Teaching Check | 1 | — | — |
| Recurrent Infections At 4 Months | 1 | — | — |
| New Movement Changes At Day 60 | 1 | — | — |
| New Lymphoma After Therapy | 1 | — | — |
| Length of Follow-Up | 1 | — | — |
| Stopping A Prophylactic Drug | 1 | — | — |
| Monitoring B-Cell Counts | 1 | — | — |
| Protecting The Household | 1 | — | — |
| Standards | 1 | — | — |
| Care | 1 | — | — |
| Lymphoid Lineage | 1 | — | — |
| Specific Antibodies | 1 | — | — |
| Depleted Graft | 1 | — | — |
| Hsct For Scid | 1 | — | — |
| Tapering Immunosuppression At Relapse | 1 | — | — |
| Costimulatory Domain | 1 | — | — |
| Relapse of Large B-Cell Lymphoma | 1 | — | — |
| Target In Myeloma | 1 | — | — |
| Hlh | 1 | — | — |
| Mismatched Unrelated Donor | 1 | — | — |
| Teaching After Dli | 1 | — | — |
| Cells Need Less Matching | 1 | — | — |
| Bispecific In Lung Cancer | 1 | — | — |
| Therapy Versus Sibling Hsct | 1 | — | — |
| Marrow Harvest | 1 | — | — |
| Cord Blood Units | 1 | — | — |
| Starting Material | 1 | — | — |
| Early Posttransplant Management and Education | 1 | 4 | 36 |
| Selecting Between Sibling Donors | 1 | — | — |
| Right To Withdraw | 1 | — | — |
| Planning Lodging For Car T | 1 | — | — |
| Pcr | 1 | — | — |
| Prophylaxis Candidate | 1 | — | — |
| After Engraftment | 1 | — | — |
| Diarrhea On Steroids | 1 | — | — |
| Diarrhea | 1 | — | — |
| Falling Counts | 1 | — | — |
| For A Drug-Level Draw | 1 | — | — |
| Transplant Cyclophosphamide Day | 1 | — | — |
| Platelet Unit | 1 | — | — |
| Lung Infiltrates | 1 | — | — |
| At Home | 1 | — | — |
| Transfusion Response | 1 | — | — |
| Fever With Nodules | 1 | — | — |
| Severity Score | 1 | — | — |
| Review For Cgvhd | 1 | — | — |
| Gritty Eyes | 1 | — | — |
| Live Vaccine | 1 | — | — |
| Pneumococcal Vaccines | 1 | — | — |
| Periods and Hot Flashes | 1 | — | — |
| Cytopenias Years Later | 1 | — | — |
| +180 Results | 1 | — | — |
| Steroid Survivor | 1 | — | — |
| Two Drugs For Blood Pressure | 1 | — | — |
| Grading Without Fever | 1 | — | — |
| Brief Seizure, Moderate Ice | 1 | — | — |
| Weight-Based Dose Check | 1 | — | — |
| Subtle Change In Writing | 1 | — | — |
| Fever Plus Confusion | 1 | — | — |
| Hyperinflammation As Crs Ends | 1 | — | — |
| Missed Treatment Week | 1 | — | — |
| Symptoms At Home After A Dose | 1 | — | — |
| Taste Change and Weight Loss | 1 | — | — |
| Special Blood Product Order | 1 | — | — |
| Hypotension In Week Three | 1 | — | — |
| Pre-Infusion Risk Factors | 1 | — | — |
| First Response Assessment | 1 | — | — |
| One-Sided Facial Weakness | 1 | — | — |
| Vaccine To Postpone | 1 | — | — |
| Counts Still Low At 3 Months | 1 | — | — |
| Foundations of Transplant | 1 | 3 | 33 |
| Driving Teaching Check | 1 | — | — |
| Boxed Warning Question | 1 | — | — |
| Exposure At Home | 1 | — | — |
| Moving To Another State | 1 | — | — |
| Disagreement | 1 | — | — |
| After Discharge | 1 | — | — |
| Late Posttransplant Management and Education | — | 3 | 23 |
